Clinical Trial Update: Safety and Pharmacodynamics Study of AGN-207281 Ophthalmic Solutions Compared With Timolol Ophthalmic Solution or Placebo in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma [Phase 1]

View source ↗

Summary

Phase 1 safety and pharmacodynamics study of AGN-207281 ophthalmic solution compared with timolol ophthalmic solution or placebo in ocular hypertension and prim…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• AGN-207281 ophthalmic solution (AGN-207281)
• Timolol ophthalmic solution (timolol)

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Open-Angle, Ocular Hypertension | Phase 1 | Status: COMPLETED | Results posted: 2012-01-16